Chardan NexTech Acquisition ^{Withdrawn, Nasdaq: CNAQU}

We are a blank check company. While we may pursue an initial business combination target in any industry or sector, we intend to focus our search on disruptive technology companies that operate within the HealthTech and FinTech sectors. Our focus on disruptive technologies in both HealthTech and FinTech, is aligned with the investment expertise, relationships, proprietary deal flow, and connectivity of our management team, board of directors, and Chardan. Through our multiple decades of special purpose acquisition, sector, direct investment, and investment banking advisory experiences, our sponsor and management team receive proprietary access to a strong pipeline of disruptive technology investment opportunities. As Chardan’s healthcare, special purpose acquisition company advisory and principal special purpose acquisition company practices have expanded, our inbound deal flow in HealthTech has significantly increased as private companies seek out our proprietary expertise. Through our FinTech investment banking practice and the business experience of our board of directors, we will be able to capitalize on our collective domain expertise and proprietary deal flow in that sector.